Emily Roberts
Lawyers
Filters
RAPT Therapeutics $250 million follow-on offering
The shares are listed on the Nasdaq Global Market
Nurix Therapeutics $250 million stock offering
The stock is listed on the Nasdaq Global Market
Credo Technology $750 million at-the-market offering
We advised Credo on the offering
Applied Materials $1 billion senior notes offering
The investment-grade notes are due 2031 and 2036
Enovix $360 million convertible senior notes and capped call transactions
The 4.75% convertible notes are due 2030
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
Uber Technologies $2.25 billion senior notes offering
The investment-grade notes are due 2031 and 2035
Nextracker acquisition of Origami Solar
We advised Nextracker on the acquisition
Mavenir Systems comprehensive out-of-court debt recapitalization
We advised an ad hoc group of term loan lenders on the transaction
Data center company defense for potential approach by Elliott Management
We advised the company on this potential activist approach